The work in this thesis details the design of new malaria vaccine candidates based on blood-stage antigen merozoite surface protein 2 (MSP2). Structural biology and vaccine design were combined in the emerging field of structural vaccinology and applied to the intrinsically disordered protein. Using crystal structures of antibody-bound epitopes, novel peptide immunogens were designed for animal immunisations. The results of this work provide a promising platform for further development of broadly protective MSP2-based malaria vaccine candidates and may expand our understanding of the immune response towards other disordered antigens
Plasmodium parasites are the causative agent of human malaria, and the development of a highly effec...
Synthetic peptides representing conserved MSA-2 sequences are being considered as a possible compone...
Obtaining a highly effective malaria vaccine is a worldwide priority. The first approach aimed at ob...
The malaria vaccine candidate merozoite surface protein 2 (MSP2) has shown promise in clinical trial...
Merozoite surface protein 2 (MSP2) is an intrinsically disordered antigen that is abundant on the su...
Merozoite surface protein 2 (MSP2) is an intrinsically disordered antigen that is abundant on the su...
Merozoite surface protein 2 (MSP2) is an intrinsically disordered antigen that is abundant on the su...
merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneous...
merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneous...
MSP2 is an intrinsically disordered protein that is abundant on the merozoite surface and essential ...
MSP2 is an intrinsically disordered protein that is abundant on the merozoite surface and essential ...
The work in this thesis describes the efforts to enhance the efficacy of malaria vaccine candidates ...
Developing an efficacious vaccine for the vector-borne infectious disease, Malaria, remains a top pr...
Plasmodium parasites are the causative agent of human malaria, and the development of a highly effec...
Malaria represents a major public health problem and an important cause of mortality and morbidity. ...
Plasmodium parasites are the causative agent of human malaria, and the development of a highly effec...
Synthetic peptides representing conserved MSA-2 sequences are being considered as a possible compone...
Obtaining a highly effective malaria vaccine is a worldwide priority. The first approach aimed at ob...
The malaria vaccine candidate merozoite surface protein 2 (MSP2) has shown promise in clinical trial...
Merozoite surface protein 2 (MSP2) is an intrinsically disordered antigen that is abundant on the su...
Merozoite surface protein 2 (MSP2) is an intrinsically disordered antigen that is abundant on the su...
Merozoite surface protein 2 (MSP2) is an intrinsically disordered antigen that is abundant on the su...
merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneous...
merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneous...
MSP2 is an intrinsically disordered protein that is abundant on the merozoite surface and essential ...
MSP2 is an intrinsically disordered protein that is abundant on the merozoite surface and essential ...
The work in this thesis describes the efforts to enhance the efficacy of malaria vaccine candidates ...
Developing an efficacious vaccine for the vector-borne infectious disease, Malaria, remains a top pr...
Plasmodium parasites are the causative agent of human malaria, and the development of a highly effec...
Malaria represents a major public health problem and an important cause of mortality and morbidity. ...
Plasmodium parasites are the causative agent of human malaria, and the development of a highly effec...
Synthetic peptides representing conserved MSA-2 sequences are being considered as a possible compone...
Obtaining a highly effective malaria vaccine is a worldwide priority. The first approach aimed at ob...